TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Market Closed 04-24 16:00:00 EDT

110.93

-2.28

-2.01%

盘后110.45

-0.48-0.43%

19:54 EDT

High114.09	Low109.14	Vol808.39K
Open114.09	D1 Closing113.21	Amplitude4.37%
Mkt Cap3.83B	Tradable Cap3.66B	Total Shares34.54M
T/O89.49M	T/O Rate2.45%	Tradable Shares32.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":110.93,"timestamp":1777060800000,"preClose":113.21,"halted":0,"volume":808385,"hourTrading":{"tag":"盘后","latestPrice":110.45,"preClose":110.93,"latestTime":"19:54 EDT","volume":17776,"amount":1971955.9616,"timestamp":1777074861647,"change":-0.48,"changeRate":-0.004327,"amplitude":0.005382},"delay":0,"changeRate":-0.020139563642787624,"floatShares":32954993,"shares":34544158,"eps":4.87,"marketStatus":"Market Closed","change":-2.28,"latestTime":"04-24 16:00:00 EDT","open":114.09,"high":114.09,"low":109.14,"amount":89494799.7539,"amplitude":0.043724,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.87,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":113.21,"preHourTrading":{"tag":"盘前","latestPrice":114,"preClose":113.21,"latestTime":"08:32 EDT","volume":862,"amount":98287.76566,"timestamp":1777033926110,"change":0.79,"changeRate":0.006978,"amplitude":0.054071},"postHourTrading":{"tag":"盘后","latestPrice":110.45,"preClose":110.93,"latestTime":"19:54 EDT","volume":17776,"amount":1971955.9616,"timestamp":1777074861647,"change":-0.48,"changeRate":-0.004327,"amplitude":0.005382},"volumeRatio":0.9597285330188042,"impliedVol":0.816,"impliedVolPercentile":0.7928},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2629483360","title":"TransMedics to update clinical programs at ISHLT annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629483360","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629483360?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:08","pubTimestamp":1776942491,"startTime":"0","endTime":"0","summary":"TransMedics will provide an update on ongoing heart and lung clinical programs at International Society of Heart and Lung Transplantation 2026 Annual Meeting in Toronto.Company plans to unveil Controlled Hypothermic Organ Preservation System at event to support enrollment of control arms for OCS ENHANCE Heart Part B trial and OCS DENOVO Lung trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL4tc3Ww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2324357040.USD","TMDX","LU2065731478.USD","BK4082","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629838257","title":"Transmedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629838257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629838257?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA49JLHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","BK4588","BK4082","TMDX","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629057446","title":"TransMedics schedules first-quarter financial results conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2629057446","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629057446?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:05","pubTimestamp":1776801940,"startTime":"0","endTime":"0","summary":"TransMedics schedules first-quarter 2026 financial results release for May 5, 2026.Management conference call set for May 5, 2026 at 4:30 p.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL8p2lsX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX","LU2065731478.USD","BK4082","LU2324357040.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626019217","title":"TransMedics announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2626019217","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626019217?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:49","pubTimestamp":1775821793,"startTime":"0","endTime":"0","summary":"Shareholders will vote to elect eight directors for terms running to 2027 annual meeting.Advisory vote set on named executive officer compensation.Meeting agenda includes vote on amending 2019 stock incentive plan, including adding 2,750,000 shares for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLb72ghX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","LU2324357040.USD","BK4082","TMDX","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625381952","title":"TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2625381952","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625381952?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:57","pubTimestamp":1775577421,"startTime":"0","endTime":"0","summary":"TransMedics Group  is facing \"misplaced\" concerns over increasing jet fuel prices' impact on its logistics margins, Oppenheimer said in a Tuesday note.Based on conversations with industry players, Oppenheimer said TransMedics is passing on incremental fuel surcharges of up to $5,000 per flight to hospitals. The investment firm said \"surcharge pass-throughs\" is standard in hospital contracts for organ transplant logistics providers.Even if the company had to shoulder the incremental costs, the estimated total impact in Q1 is about $2.5 million to $5 million based on flight hours, the brokerage added. A $5 million impact will cut Q1 gross margins by 270 basis points and earnings per share by about 15%, Oppenheimer added.Oppenheimer has an outperform rating on TransMedics Group, with a $175 price target.Price: 106.79, Change: +1.99, Percent Change: +1.89","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065731478.USD","LU2324357040.USD","BK4082","BK4127","OPY","BK4585","BK4588","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625260397","title":"TransMedics Group Is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2625260397","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625260397?lang=en_us&edition=fundamental","pubTime":"2026-04-07 01:49","pubTimestamp":1775497740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 06, 2026 13:49 ET (17:49 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX","BK4588","BK4585","BK4082","LU2065731478.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624048510","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624048510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624048510?lang=en_us&edition=fundamental","pubTime":"2026-04-02 00:20","pubTimestamp":1775060411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TransMedics Group (TMDX) and Humacyte (HUMA) with bu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","LU0029874061.USD","HUMA","LU2065731478.USD","TMDX","HCSG","XBI","BK4137","BK4563","LABU","BK4082","XLV","BK4581","BK4139","LU2324357040.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620495622","title":"Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), HOYA (OtherHOCPF) and TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620495622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620495622?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:10","pubTimestamp":1773915009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN), HOYA (HOCPF) and Tra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arvinas-holding-company-arvn-hoya-otherhocpf-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arvinas-holding-company-arvn-hoya-otherhocpf-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TMDX","BK4588","BK4198","BK4137","BK4581","LU0128526141.USD","LU2324357040.USD","XLV","HOCPF","LABU","BK4082","ARVN","BK4585","XBI","LU2065731478.USD","HCSG","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619217052","title":"Kidney Expansion And Strong Outlook Might Change The Case For Investing In TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619217052","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619217052?lang=en_us&edition=fundamental","pubTime":"2026-03-15 14:21","pubTimestamp":1773555713,"startTime":"0","endTime":"0","summary":"In recent weeks, TransMedics Group reported fourth-quarter results that exceeded analyst expectations and updated investors with what analysts described as a strong 2026 outlook.\nAnalysts highlighted the company’s continued investment in heart and lung transplant technology and its intention to expand into kidney, underscoring confidence in its clinical platform.\nBuilding on this upbeat outlook and kidney expansion focus, we’ll now explore how the latest developments may reshape TransMedics’...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/kidney-expansion-and-strong-outlook-might-change-the-case-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/kidney-expansion-and-strong-outlook-might-change-the-case-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065731478.USD","BK4588","BK4082","TMDX","BK4585","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619143299","title":"TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2619143299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619143299?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:30","pubTimestamp":1773437449,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary. TransMedics Group, Inc. filed an initial statement of beneficial ownership for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLbRkMPp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","LU2065731478.USD","TMDX","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618628818","title":"Transmedics Group Inc : Stifel Raises Target Price to $130 From $115","url":"https://stock-news.laohu8.com/highlight/detail?id=2618628818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618628818?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:13","pubTimestamp":1773054818,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","BK4585","LU2324357040.USD","BK4588","BK4082","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617551416","title":"TransMedics Director David Weill Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617551416","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617551416?lang=en_us&edition=fundamental","pubTime":"2026-03-07 07:09","pubTimestamp":1772838597,"startTime":"0","endTime":"0","summary":"David Weill, a director of TransMedics Group, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDLD8Hl4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Director David Weill Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4082","LU2065731478.USD","BK4588","TMDX","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617333599","title":"TransMedics CFO Gerardo Hernandez Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617333599","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617333599?lang=en_us&edition=fundamental","pubTime":"2026-03-05 10:41","pubTimestamp":1772678470,"startTime":"0","endTime":"0","summary":"Gerardo Hernandez, Chief Financial Officer of TransMedics Group, Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL8xd1gG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics CFO Gerardo Hernandez Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2065731478.USD","LU2324357040.USD","TMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616347030","title":"Piper Sandler Sticks to Their Buy Rating for TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347030?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:29","pubTimestamp":1772540995,"startTime":"0","endTime":"0","summary":"In a report released today,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190510354","title":"Stock Track | TransMedics Soars 5.18% Intraday on Tax Benefit Boosting Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1190510354","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190510354?lang=en_us&edition=fundamental","pubTime":"2026-02-27 23:26","pubTimestamp":1772206016,"startTime":"0","endTime":"0","summary":"Shares of TransMedics Group, Inc. surged 5.18% during intraday trading on Friday, following the company's disclosure of a significant one-time tax benefit that dramatically improved its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614853563","title":"Transmedics Provides Information On Impact Of Release Of Valuation Allowance On Deferred Tax Assets On Previously Reported Quarterly Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614853563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614853563?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:25","pubTimestamp":1772195150,"startTime":"0","endTime":"0","summary":"Feb 27 (Reuters) - Transmedics Group Inc ::*TRANSMEDICS PROVIDES ADDITIONAL INFORMATION ON THE IMPACT OF THE RELEASE OF THE VALUATION ALLOWANCE ON DEFERRED TAX ASSETS ON PREVIOUSLY REPORTED FOURTH QUA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nRSD7yqBvD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMDX","LU2065731478.USD","LU2324357040.USD","BK4082","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614893858","title":"TransMedics Q4 net income hits USD 105.4 million on a FY effective tax rate of (77.0)%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614893858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614893858?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:01","pubTimestamp":1772193690,"startTime":"0","endTime":"0","summary":"TransMedics said it released a USD 103.3 million U.S. tax valuation allowance in Q4 2025, resulting in a net income tax benefit of USD 83.8 million. For Q4 2025, TransMedics reported income before income taxes of USD 21.6 million, net income of USD 105.4 million and diluted EPS of USD 2.62. The company said its FY 2025 effective tax rate was % and that, excluding the valuation allowance release, the FY 2025 effective tax rate was 19.1%. TransMedics added that it expects future quarterly income tax provisions to be more in line with U.S. statutory corporate income tax rates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL1ZsMcc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2065731478.USD","LU2324357040.USD","BK4588","TMDX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614398858","title":"Press Release: TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614398858","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614398858?lang=en_us&edition=fundamental","pubTime":"2026-02-27 20:00","pubTimestamp":1772193600,"startTime":"0","endTime":"0","summary":"ANDOVER, Mass., Feb. 27, 2026 /PRNewswire/ -- TransMedics Group, Inc.  , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today issued additional information on the impact of the valuation allowance on deferred tax assets reported in the Company's fourth quarter financial results for the year ended December 31, 2025.As previously disclosed, in the fourth quarter of 2025, TransMedics released a $103.3 million U.S. tax valuation allowance, which drove recognition of a net income tax benefit of $83.8 million in the fourth quarter. The Company released the U.S. tax valuation allowance because it determined that it had become more likely than not that future income would result in use of deferred tax assets.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4134","BK4099","BK4555","LU2065731478.USD","LU2324357040.USD","III","BK4604","TMDX","03160","TM","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614503977","title":"Stifel Nicolaus Remains a Hold on TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614503977","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614503977?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:56","pubTimestamp":1772035000,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Stephan from Stifel Nicolaus maintained a Hold rating on TransMedics Group, with a price target of $115.00. Step...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-hold-on-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-hold-on-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4585","BK4082","SF","BK4127","TMDX","LU2065731478.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614080775","title":"Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2614080775","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614080775?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:51","pubTimestamp":1772027467,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $159, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4585","BK4082","TMDX","LU2065731478.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":-0.0426},{"period":"1month","weight":0.0552},{"period":"3month","weight":-0.1801},{"period":"6month","weight":-0.1501},{"period":"1year","weight":0.1779},{"period":"ytd","weight":-0.0881}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.026649},{"month":2,"riseRate":0.714286,"avgChangeRate":0.153587},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.028866},{"month":4,"riseRate":0.714286,"avgChangeRate":0.10979},{"month":5,"riseRate":0.5,"avgChangeRate":0.127373},{"month":6,"riseRate":1,"avgChangeRate":0.158462},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.012617},{"month":8,"riseRate":0.571429,"avgChangeRate":0.040414},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.096617},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.026786}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}